# FDA Inspection 1264165 - Cedars-Sinai Medical Center - March 14, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/cedars-sinai-medical-center/102c1816-ca50-473c-8849-07bb48f50c3d/
Source feed: FDA_Inspections

> FDA Inspection 1264165 for Cedars-Sinai Medical Center on March 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264165
- Company Name: Cedars-Sinai Medical Center
- Inspection Date: 2025-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1264165 - 2025-03-14](https://www.globalkeysolutions.net/api/records/fda_inspections/cedars-sinai-medical-center/1f454784-92c3-4df4-8a0b-fb2cda905cfc/)
- [FDA Inspection 1178792 - 2022-08-26](https://www.globalkeysolutions.net/api/records/fda_inspections/cedars-sinai-medical-center/e0a9a5d2-5267-4e83-8470-19cc616b7177/)
- [FDA Inspection 1178792 - 2022-08-26](https://www.globalkeysolutions.net/api/records/fda_inspections/cedars-sinai-medical-center/6baa2506-738b-4f21-9ead-13ef4db5dce7/)
- [FDA Inspection 1048111 - 2018-02-27](https://www.globalkeysolutions.net/api/records/fda_inspections/cedars-sinai-medical-center/9b2ef861-00f1-47da-a4f7-b6fbe4961832/)
- [FDA Inspection 983245 - 2016-03-28](https://www.globalkeysolutions.net/api/records/fda_inspections/cedars-sinai-medical-center/31f9ab48-f314-42d9-aaa3-49d77eda83fd/)

Company: https://www.globalkeysolutions.net/companies/cedars-sinai-medical-center/0c040871-8a84-423c-ae2b-2a7748ab8111

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d